<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33803845</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>18</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">676</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10030676</ELocationID><Abstract><AbstractText>Transactive response DNA-binding protein 43 (TDP-43) is a ubiquitously expressed DNA/RNA-binding protein linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). TDP-43 has been implicated in numerous aspects of the mRNA life cycle, as well as in cell toxicity and neuroinflammation. In this study, we used the toxicity of the TDP-43 expression in <i>Saccharomyces cerevisiae</i> as an assay to identify <i>TDP-43</i> genetic interactions. Specifically, we transformed human <i>TDP-43</i> cDNAs of wild-type or disease-associated mutants (<i>M337V</i> and <i>Q331K</i>) en masse into 4653 homozygous diploid yeast deletion mutants and then used next-generation sequencing readouts of growth to identify yeast toxicity modifiers. Genetic interaction analysis provided a global view of TDP-43 pathways, some of which are known to be involved in cellular metabolic processes. Selected putative loci with the potential of genetic interactions with <i>TDP-43</i> were assessed for associations with neurotoxicity and inflammatory activation of astrocytes. The pharmacological inhibition of succinate dehydrogenase flavoprotein subunit A (SDHA) and voltage-dependent anion-selective channel 3 (VDAC3) suppressed TDP-43-induced expression of proinflammatory cytokines in astrocytes, indicating the critical roles played by SDHA and VDAC3 in TDP-43 pathways during inflammatory activation of astrocytes and neuroinflammation. Thus, the findings of our <i>TDP-43</i> genetic interaction screen provide a global landscape of TDP-43 pathways and may help improve our understanding of the roles of glia and neuroinflammation in ALS and FTD pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae-Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BK21 Plus KNU Biomedical Convergence Program, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu 412944, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Md Habibur</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BK21 Plus KNU Biomedical Convergence Program, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu 412944, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Science &amp; Engineering Institute, Kyungpook National University, Daegu 41566, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Donghwi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Myungjin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyung-Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Dementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suk</LastName><ForeName>Kyoungho</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9555-4203</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BK21 Plus KNU Biomedical Convergence Program, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu 412944, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Science &amp; Engineering Institute, Kyungpook National University, Daegu 41566, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018R1A2A1A05077118, 2016M3C7A1904148, NRF-2017R1A5A2015391, and NRF-2020M3E5D9079764</GrantID><Agency>National Research Foundation (NRF), which is funded by the Korean government</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">astrocyte</Keyword><Keyword MajorTopicYN="N">genetic interaction</Keyword><Keyword MajorTopicYN="N">glia</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33803845</ArticleId><ArticleId IdType="pmc">PMC8003223</ArticleId><ArticleId IdType="doi">10.3390/cells10030676</ArticleId><ArticleId IdType="pii">cells10030676</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Buratti E., Baralle F.E. TDP-43: Gumming up neurons through protein-protein and protein-RNA interactions. Trends Biochem. Sci. 2012;37:237&#x2013;247. doi: 10.1016/j.tibs.2012.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2012.03.003</ArticleId><ArticleId IdType="pubmed">22534659</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Chen H.J., Shaw C.E. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics. 2015;12:352&#x2013;363. doi: 10.1007/s13311-015-0338-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId><ArticleId IdType="pmc">PMC4404432</ArticleId><ArticleId IdType="pubmed">25652699</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.F., Gendron T.F., Zhang Y.J., Lin W.L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., et al. Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice. J. Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Komine O. The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 2018;126:31&#x2013;38. doi: 10.1016/j.neures.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Ghasemi M., Brown R.H., Jr. Emerging mechanisms of molecular pathology in ALS. J. Clin. Investig. 2015;125:2548. doi: 10.1172/JCI82693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI82693</ArticleId><ArticleId IdType="pmc">PMC4518693</ArticleId><ArticleId IdType="pubmed">26030230</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F., Cortes N., Abarzua S., Dyrda A., Van Zundert B.A. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front. Cell. Neurosci. 2014;8:24. doi: 10.3389/fncel.2014.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00024</ArticleId><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J., Huang C., Bi F., Wu Q., Huang B., Liu X., Li F., Zhou H., Xia X.G. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 2013;32:1917&#x2013;1926. doi: 10.1038/emboj.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan S.A., Barres B.A. Glia as primary drivers of neuropathology in TDP-43 proteinopathies. Proc. Natl. Acad. Sci. USA. 2013;110:4439&#x2013;4440. doi: 10.1073/pnas.1301608110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1301608110</ArticleId><ArticleId IdType="pmc">PMC3607032</ArticleId><ArticleId IdType="pubmed">23471990</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.H., Suk K. Mitochondrial Dynamics and Bioenergetic Alteration During Inflammatory Activation of Astrocytes. Front. Aging Neurosci. 2020;12:614410. doi: 10.3389/fnagi.2020.614410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.614410</ArticleId><ArticleId IdType="pmc">PMC7759744</ArticleId><ArticleId IdType="pubmed">33362533</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C., Guillemaud O., Sauvage M.C. Questions and (some) answers on reactive astrocytes. Glia. 2019;67:2221&#x2013;2247. doi: 10.1002/glia.23687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23687</ArticleId><ArticleId IdType="pubmed">31429127</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson M.A., Ao Y., Sofroniew M.V. Heterogeneity of reactive astrocytes. Neurosci. Lett. 2014;565:23&#x2013;29. doi: 10.1016/j.neulet.2013.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.12.030</ArticleId><ArticleId IdType="pmc">PMC3984948</ArticleId><ArticleId IdType="pubmed">24361547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32:638&#x2013;647. doi: 10.1016/j.tins.2009.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2009.08.002</ArticleId><ArticleId IdType="pmc">PMC2787735</ArticleId><ArticleId IdType="pubmed">19782411</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50:427&#x2013;434. doi: 10.1002/glia.20207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20207</ArticleId><ArticleId IdType="pubmed">15846805</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekny M., Johansson C.B., Eliasson C., Stakeberg J., Wall&#xe9;n A., Perlmann T., Lendahl U., Betsholtz C., Berthold C.H., Fris&#xe9;n J. Abnormal Reaction to Central Nervous System Injury in Mice Lacking Glial Fibrillary Acidic Protein and Vimentin. J. Cell Biol. 1999;145:503&#x2013;514. doi: 10.1083/jcb.145.3.503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.145.3.503</ArticleId><ArticleId IdType="pmc">PMC2185074</ArticleId><ArticleId IdType="pubmed">10225952</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A.U., Minhas P.S., Liddelow S.A., Haileselassie B., Andreasson K.I., Dorn G.W., II, Mochly-Rosen D. Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat. Neurosci. 2019;22:1635&#x2013;1648. doi: 10.1038/s41593-019-0486-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0486-0</ArticleId><ArticleId IdType="pmc">PMC6764589</ArticleId><ArticleId IdType="pubmed">31551592</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan K.A., Weigel M.K., Adler D.I., Couthouis J., Liddelow S.A., Gitler A.D., Barres B.A. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat. Commun. 2020;11:1&#x2013;9. doi: 10.1038/s41467-020-17514-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17514-9</ArticleId><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce P.I., Fratta P., Fisher E.M.C., Acevedo-Arozena A. SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: Recent advances in understanding disease toward the development of clinical treatments. Mamm. Genome. 2011;22:420&#x2013;448. doi: 10.1007/s00335-011-9339-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00335-011-9339-1</ArticleId><ArticleId IdType="pubmed">21706386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim S., Kang H.Y., Lim H.R., Kwon Y., Jo M., Jeon Y.M., Kim S.R., Kim K., Ha C.M., et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J. Neuroinflamm. 2020;17:1&#x2013;22. doi: 10.1186/s12974-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>Christian F., Smith E.L., Carmody R.J. The Regulation of NF-kappaB Subunits by Phosphorylation. Cells. 2016;5:12. doi: 10.3390/cells5010012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells5010012</ArticleId><ArticleId IdType="pmc">PMC4810097</ArticleId><ArticleId IdType="pubmed">26999213</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnbaum J.H., Wanner D., Gietl A.F., Saake A., Kundig T.M., Hock C., Nitsch R.M., Tackenberg C. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-beta and tau pathology in iPSC-derived neurons from sporadic Alzheimer&#x2019;s disease patients. Stem Cell Res. 2018;27:121&#x2013;130. doi: 10.1016/j.scr.2018.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.01.019</ArticleId><ArticleId IdType="pubmed">29414602</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautier C.A., Corti O., Brice A. Mitochondrial dysfunctions in Parkinson&#x2019;s disease. Rev. Neurol. 2014;170:339&#x2013;343. doi: 10.1016/j.neurol.2013.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2013.06.003</ArticleId><ArticleId IdType="pubmed">24119854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M., Carr&#xec; M.T. Mitochondrial dysfunction in ALS. Prog. Neurobiol. 2012;97:54&#x2013;66. doi: 10.1016/j.pneurobio.2011.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.06.003</ArticleId><ArticleId IdType="pubmed">21827820</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S., Gitler A.D., Lindquist S. A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast. 2007;24:913&#x2013;919. doi: 10.1002/yea.1502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/yea.1502</ArticleId><ArticleId IdType="pmc">PMC2190539</ArticleId><ArticleId IdType="pubmed">17583893</ArticleId></ArticleIdList></Reference><Reference><Citation>Gietz R.D., Schiestl R.H. High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat. Protoc. 2007;2:31&#x2013;34. doi: 10.1038/nprot.2007.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.13</ArticleId><ArticleId IdType="pubmed">17401334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Seo Y., Jo M., Jeon H., Kim Y.S., Kim E.J., Seo D., Lee W.H., Kim S.R., Yachie N., et al. Interrogation of kinase genetic interactions provides a global view of PAK1-mediated signal transduction pathways. J. Biol. Chem. 2020;295:16906&#x2013;16919. doi: 10.1074/jbc.RA120.014831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.014831</ArticleId><ArticleId IdType="pmc">PMC7863907</ArticleId><ArticleId IdType="pubmed">33060198</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Seo Y., Jo M., Jeon H., Lee W.H., Yachie N., Zhong Q., Vidal M., Roth F.P., Suk K. Yeast-Based Genetic Interaction Analysis of Human Kinome. Cells. 2020;9:1156. doi: 10.3390/cells9051156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051156</ArticleId><ArticleId IdType="pmc">PMC7291280</ArticleId><ArticleId IdType="pubmed">32392905</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M., Chung A.Y., Yachie N., Seo M., Jeon H., Nam Y., Seo Y., Kim E., Zhong Q., Vidal M., et al. Yeast genetic interaction screen of human genes associated with amyotrophic lateral sclerosis: Identification of MAP2K5 kinase as a potential drug target. Genome Res. 2017;27:1487&#x2013;1500. doi: 10.1101/gr.211649.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.211649.116</ArticleId><ArticleId IdType="pmc">PMC5580709</ArticleId><ArticleId IdType="pubmed">28596290</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi S., Ray D., Warde-Farley D., Grouios C., Morris Q.D. GeneMANIA: A real-time multiple association network integration algorithm for predicting gene function. Genome Biol. 2008;9:S4. doi: 10.1186/gb-2008-9-s1-s4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2008-9-s1-s4</ArticleId><ArticleId IdType="pmc">PMC2447538</ArticleId><ArticleId IdType="pubmed">18613948</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2013;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44&#x2013;57. doi: 10.1038/nprot.2008.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.211</ArticleId><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Ko P.W., Lee H.W., Jeong J.Y., Lee M.G., Kim J.H., Lee W.H., Yu R., Oh W.J., Suk K. Astrocyte-derived lipocalin-2 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia. Glia. 2017;65:1471&#x2013;1490. doi: 10.1002/glia.23174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23174</ArticleId><ArticleId IdType="pubmed">28581123</ArticleId></ArticleIdList></Reference><Reference><Citation>Motori E., Puyal J., Toni N., Ghanem A., Angeloni C., Malaguti M., Cantelli-Forti G., Berninger B., Conzelmann K.K., G&#xf6;tz M., et al. Inflammation-Induced Alteration of Astrocyte Mitochondrial Dynamics Requires Autophagy for Mitochondrial Network Maintenance. Cell Metab. 2013;18:844&#x2013;859. doi: 10.1016/j.cmet.2013.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.11.005</ArticleId><ArticleId IdType="pubmed">24315370</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieke S.M., Phillips D., McCoy J.P., Aponte A.M., Shen R.F., Balaban R.S., Finkel T. The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity. J. Biol. Chem. 2006;281:27643&#x2013;27652. doi: 10.1074/jbc.M603536200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M603536200</ArticleId><ArticleId IdType="pubmed">16847060</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402&#x2013;408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Uderhardt S., Ackermann J.A., Fillep T., Hammond V.J., Willeit J., Santer P., Mayr M., Biburger M., Miller M., Zellner K.R., et al. Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease. J. Exp. Med. 2017;214:2121&#x2013;2138. doi: 10.1084/jem.20161070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161070</ArticleId><ArticleId IdType="pmc">PMC5502424</ArticleId><ArticleId IdType="pubmed">28566277</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., et al. The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clin. Chem. 2009;55:611&#x2013;622. doi: 10.1373/clinchem.2008.112797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2008.112797</ArticleId><ArticleId IdType="pubmed">19246619</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones S.R., Carley S., Harrison M. An introduction to power and sample size estimation. Emerg. Med. J. 2003;20:453&#x2013;458. doi: 10.1136/emj.20.5.453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emj.20.5.453</ArticleId><ArticleId IdType="pmc">PMC1726174</ArticleId><ArticleId IdType="pubmed">12954688</ArticleId></ArticleIdList></Reference><Reference><Citation>Giaever G., Shoemaker D.D., Jones T.W., Liang H., Winzeler E.A., Astromoff A., Davis R.W. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 1999;21:278&#x2013;283. doi: 10.1038/6791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/6791</ArticleId><ArticleId IdType="pubmed">10080179</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.M., Durbic T., Kittanakom S., Giaever G., Nislow C. Barcode Sequencing for Understanding Drug&#x2013;Gene Interactions. Adv. Struct. Saf. Stud. 2012;910:55&#x2013;69. doi: 10.1007/978-1-61779-965-5_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-965-5_4</ArticleId><ArticleId IdType="pubmed">22821592</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.M., Heisler L.E., Mellor J., Kaper F., Thompson M.J., Chee M., Roth F.P., Giaever G., Nislow C. Quantitative phenotyping via deep barcode sequencing. Genome Res. 2009;19:1836&#x2013;1842. doi: 10.1101/gr.093955.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.093955.109</ArticleId><ArticleId IdType="pmc">PMC2765281</ArticleId><ArticleId IdType="pubmed">19622793</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nat. Cell Biol. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Raphael A.R., LaDow E.S., McGurk L., Weber R.A., Trojanowski J.Q., Lee V.M.Y., Finkbeiner S., Gitler A.D., Bonini N.M. Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014;46:152&#x2013;160. doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Chitta R.K., High A.A., Taylor J.P. Global Analysis of TDP-43 Interacting Proteins Reveals Strong Association with RNA Splicing and Translation Machinery. J. Proteome Res. 2009;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Koppers M., Groen E.J.N., Heuvel D.M.A.V.D., Modigliani S.D., Anink J.J., Fumoto K., Van Diggelen F., Snelting A., Sodaar P., et al. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol. 2016;132:175&#x2013;196. doi: 10.1007/s00401-016-1575-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1575-8</ArticleId><ArticleId IdType="pmc">PMC4947123</ArticleId><ArticleId IdType="pubmed">27164932</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., Sanelli T., Dib S., Sheps D., Findlater J., Bilbao J., Keith J., Zinman L., Rogaeva E., Robertson J. RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS. Mol. Cell. Neurosci. 2011;47:167&#x2013;180. doi: 10.1016/j.mcn.2011.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2011.02.013</ArticleId><ArticleId IdType="pubmed">21421050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K.P., Remm M., Sonnhammer E.L. Inparanoid: A comprehensive database of eukaryotic orthologs. Nucleic Acids Res. 2005;33:D476&#x2013;D480. doi: 10.1093/nar/gki107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki107</ArticleId><ArticleId IdType="pmc">PMC540061</ArticleId><ArticleId IdType="pubmed">15608241</ArticleId></ArticleIdList></Reference><Reference><Citation>Montojo J., Zuberi K., Rodriguez H., Kazi F., Wright G., Donaldson S.L., Morris Q., Bader G.D. GeneMANIA Cytoscape plugin: Fast gene function predictions on the desktop. Bioinformatics. 2010;26:2927&#x2013;2928. doi: 10.1093/bioinformatics/btq562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq562</ArticleId><ArticleId IdType="pmc">PMC2971582</ArticleId><ArticleId IdType="pubmed">20926419</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.L., Wu L.S., Lee M., Chang C.W., Cheng W.C., Fang Y.S., Chen Y.R., Cheng P.L., Shen C.K.J. A robust TDP-43 knock-in mouse model of ALS. Acta Neuropathol. Commun. 2020;8:1&#x2013;19. doi: 10.1186/s40478-020-0881-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-0881-5</ArticleId><ArticleId IdType="pmc">PMC6975031</ArticleId><ArticleId IdType="pubmed">31964415</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.Y., Yeh P.A., Chiu H.C., Tang C.Y., Tu B.P.H. Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation. PLoS ONE. 2011;6:e23075. doi: 10.1371/journal.pone.0023075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023075</ArticleId><ArticleId IdType="pmc">PMC3151276</ArticleId><ArticleId IdType="pubmed">21850253</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink J.M., Dobyns W.B., Guerrini R., Hirsch B.A. Identification of a Duplication of Xq28 Associated with Bilateral Periventricular Nodular Heterotopia. Am. J. Hum. Genet. 1997;61:379&#x2013;387. doi: 10.1086/514863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/514863</ArticleId><ArticleId IdType="pmc">PMC1715887</ArticleId><ArticleId IdType="pubmed">9311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal M., Cusick M.E., Barab&#xe1;si A.L. Interactome Networks and Human Disease. Cell. 2011;144:986&#x2013;998. doi: 10.1016/j.cell.2011.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.016</ArticleId><ArticleId IdType="pmc">PMC3102045</ArticleId><ArticleId IdType="pubmed">21414488</ArticleId></ArticleIdList></Reference><Reference><Citation>Barab&#xe1;si A.L., Gulbahce N., Loscalzo J. Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 2010;12:56&#x2013;68. doi: 10.1038/nrg2918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2918</ArticleId><ArticleId IdType="pmc">PMC3140052</ArticleId><ArticleId IdType="pubmed">21164525</ArticleId></ArticleIdList></Reference><Reference><Citation>Capitanio D., Vasso M., Ratti A., Grignaschi G., Volta M., Moriggi M., Daleno C., Bendotti C., Silani V., Gelfi C. Molecular Signatures of Amyotrophic Lateral Sclerosis Disease Progression in Hind and Forelimb Muscles of an SOD1G93A Mouse Model. Antioxid. Redox Signal. 2012;17:1333&#x2013;1350. doi: 10.1089/ars.2012.4524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.4524</ArticleId><ArticleId IdType="pmc">PMC3437050</ArticleId><ArticleId IdType="pubmed">22563797</ArticleId></ArticleIdList></Reference><Reference><Citation>Yik W.Y., Steinberg S.J., Moser A.B., Moser H.W., Hacia J.G. Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders. Hum. Mutat. 2009;30:E467&#x2013;E480. doi: 10.1002/humu.20932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20932</ArticleId><ArticleId IdType="pmc">PMC2649967</ArticleId><ArticleId IdType="pubmed">19105186</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg S., Chen L., Wei L., Moser A., Moser H., Cutting G., Braverman N. The PEX Gene Screen: Molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. Mol. Genet. Metab. 2004;83:252&#x2013;263. doi: 10.1016/j.ymgme.2004.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2004.08.008</ArticleId><ArticleId IdType="pubmed">15542397</ArticleId></ArticleIdList></Reference><Reference><Citation>Bri&#xe8;re J.J., Favier J., B&#xe9;nit P., El Ghouzzi V., Lorenzato A., Rabier D., Di Renzo M.F., Gimenez-Roqueplo A.P., Rustin P. Mitochondrial succinate is instrumental for HIF1&#x3b1; nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. Hum. Mol. Genet. 2005;14:3263&#x2013;3269. doi: 10.1093/hmg/ddi359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi359</ArticleId><ArticleId IdType="pubmed">16195397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustin P., R&#xf6;tig A. Inborn errors of complex II&#x2014;Unusual human mitochondrial diseases. Biochim. Biophys. Acta Bioenerg. 2002;1553:117&#x2013;122. doi: 10.1016/S0005-2728(01)00228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0005-2728(01)00228-6</ArticleId><ArticleId IdType="pubmed">11803021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138:95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G., Coyne A.N., Pei F., Vaughan S., Chaung M., Zarnescu D.C., Buchan J.R. Endocytosis regulates TDP-43 toxicity and turnover. Nat. Commun. 2017;8:1&#x2013;14. doi: 10.1038/s41467-017-02017-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02017-x</ArticleId><ArticleId IdType="pmc">PMC5727062</ArticleId><ArticleId IdType="pubmed">29233983</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung C.Y., Berson A., Kennerdell J.R., Sartoris A., Unger T., Porta S., Kim H.J., Smith E.R., Shilatifard A., Van Deerlin V., et al. Author Correction: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity. Nat. Commun. 2019;10:555. doi: 10.1038/s41467-019-08562-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-08562-x</ArticleId><ArticleId IdType="pmc">PMC6351651</ArticleId><ArticleId IdType="pubmed">30696825</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.K., Spiller K.J., Ge G., Zheng A., Xu Y., Zhou M., Tripathy K., Kwong L.K., Trojanowski J.Q., Lee V.M.Y. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130:643&#x2013;660. doi: 10.1007/s00401-015-1460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Lin L., Tradewell M.L., Dion P.A., Bercier V., Bourgouin P., Rochefort D., Hadj S.B., Durham H.D., Velde C.V., et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 2009;19:671&#x2013;683. doi: 10.1093/hmg/ddp534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp534</ArticleId><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Velmeshev D., Hashimoto K., Huang Y.H., Hofmann J.W., Shi X., Chen J., Leidal A.M., Dishart J.G., Cahill M.K., et al. Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency. Nat. Cell Biol. 2020;588:459&#x2013;465. doi: 10.1038/s41586-020-2709-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2709-7</ArticleId><ArticleId IdType="pmc">PMC7746606</ArticleId><ArticleId IdType="pubmed">32866962</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K.J., Restrepo C.R., Khan T., Dominique M.A., Fang T.C., Canter R.G., Roberts C.J., Miller K.R., Ransohoff R.M., Trojanowski J.Q., et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B., Bs J.L.R., Irwin D.J., Grossman M., Suh E., Van Deerlin V.M., Ms E.M.W., Baek Y., et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis: A model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M., Lee S., Jeon Y.M., Kim S., Kwon Y., Kim H.J. The role of TDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies. Exp. Mol. Med. 2020;52:1652&#x2013;1662. doi: 10.1038/s12276-020-00513-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00513-7</ArticleId><ArticleId IdType="pubmed">33051572</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P.T., Dickson D.W., Trojanowski J.Q., Jack C.R., Boyle P.A., Arfanakis K., Rademakers R., Alafuzoff I., Attems J., Brayne C., et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report. Brain. 2019;142:1503&#x2013;1527. doi: 10.1093/brain/awz099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz099</ArticleId><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P., Pehar M., Vargas M.R., Castellanos R., Barbeito A.G., Est&#xe9;vez A.G., Thompson J.A., Beckman J.S., Barbeito L. Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: Implications for amyotrophic lateral sclerosis. J. Neurochem. 2005;93:38&#x2013;46. doi: 10.1111/j.1471-4159.2004.02984.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02984.x</ArticleId><ArticleId IdType="pubmed">15773903</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Bell S., Wang J., Wen S., Baloh R.H., Appel S.H. TDP-43 activates microglia through NF-kappaB and NLRP3 inflammasome. Exp. Neurol. 2015;273:24&#x2013;35. doi: 10.1016/j.expneurol.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Bilican B., Barmada S.J., Ando D.M., Zhao C., Siller R., Burr K., Haghi G., Story D., Nishimura A.L., et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2013;110:4697&#x2013;4702. doi: 10.1073/pnas.1300398110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300398110</ArticleId><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K., Huang H., Peterson A., Hu B., Maragakis N.J., Ming G.L., Chen H., Zhang S.C. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Rep. 2017;8:843&#x2013;855. doi: 10.1016/j.stemcr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Iampol G.P., Reznik N.A., Gruzdev A.D. Changes in the cellular structure of the salivary glands in Chironomus larvae resulting from mechanical cell damage. Tsitologiya. 1989;31:189&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">2734849</ArticleId></ArticleIdList></Reference><Reference><Citation>Velebit J., Horvat A., Smoli&#x10d; T., Mihevc S.P., Rogelj B., Zorec R., Vardjan N. Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca2+ signaling and dysregulated cell metabolism. Sci. Rep. 2020;10:1&#x2013;18. doi: 10.1038/s41598-020-62864-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62864-5</ArticleId><ArticleId IdType="pmc">PMC7138839</ArticleId><ArticleId IdType="pubmed">32265469</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssens J., Wils H., Kleinberger G., Joris G., Cuijt I., Groote C.C.D., Van Broeckhoven C., Kumar-Singh S. Overexpression of ALS-Associated p.M337V Human TDP-43 in Mice Worsens Disease Features Compared to Wild-type Human TDP-43 Mice. Mol. Neurobiol. 2013;48:22&#x2013;35. doi: 10.1007/s12035-013-8427-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8427-5</ArticleId><ArticleId IdType="pmc">PMC3718993</ArticleId><ArticleId IdType="pubmed">23475610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.C., Constable R., So E., Vance C., Scotter E.L., Glover L., Hortobagyi T., Arnold E.S., Ling S.C., McAlonis M.M., et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol. Commun. 2015;3:1&#x2013;16. doi: 10.1186/s40478-015-0212-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0212-4</ArticleId><ArticleId IdType="pmc">PMC4479086</ArticleId><ArticleId IdType="pubmed">26108367</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., McGettrick A.F., Goel G., Frezza C., Bernard N.J., Kelly B., Foley N.H., et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 2013;496:238&#x2013;242. doi: 10.1038/nature11986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11986</ArticleId><ArticleId IdType="pmc">PMC4031686</ArticleId><ArticleId IdType="pubmed">23535595</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Q., Chen S., Hu Q., Feng H., Zhang J.H., Tang J. NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage. Ann. Neurol. 2014;75:209&#x2013;219. doi: 10.1002/ana.24070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24070</ArticleId><ArticleId IdType="pmc">PMC4386653</ArticleId><ArticleId IdType="pubmed">24273204</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills E.L., Kelly B., Logan A., Costa A.S.H., Varma M., Bryant C.E., Tourlomousis P., D&#xe4;britz J.H.M., Gottlieb E., Latorre I., et al. Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages. Cell. 2016;167:457&#x2013;470.e13. doi: 10.1016/j.cell.2016.08.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.08.064</ArticleId><ArticleId IdType="pmc">PMC5863951</ArticleId><ArticleId IdType="pubmed">27667687</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>